A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice (Q40909623)

24 September 2017

title

A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice (English)

1 reference

24 September 2017

0 references

Brown JJ

1

1 reference

24 September 2017

Parashar B

2

1 reference

24 September 2017

Moshage H

3

1 reference

24 September 2017

Tanaka KE

4

1 reference

24 September 2017

Engelhardt D

5

1 reference

24 September 2017

Rabbani E

6

1 reference

24 September 2017

Roy-Chowdhury N

7

1 reference

24 September 2017

Roy-Chowdhury J

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

31

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

173-181

1 reference

describes a project that uses

24 September 2017

IHBV6.7

0 references

MIHA

0 references

cites work

Molecular therapeutic strategies in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

Toward routine diagnosis of hepatitis B virus desoxyribonucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

The epidemiology of hepatitis viruses B, C, and D.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Interferon and other therapies for hepatitis B and hepatitis C infections.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Selective liver targeting of antivirals by recombinant chylomicrons--a new therapeutic approach to hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Biochemical and genetic evidence for the hepatitis B virus replication strategy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Complete reconstitution of mouse liver with xenogeneic hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310126

7 January 2021

Identifiers

DOI

10.1002/HEP.510310126

1 reference

24 September 2017

1 reference